☰

Joseph A. Burlison, MS, Ph.D. - Publications

Affiliations: 
2011- J. G. Brown Cancer Center University of Louisville, Louisville, KY, United States 
Area:
Medicinal Chemistry
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 McCready J, Wong DS, Burlison JA, Ying W, Jay DG. An Impermeant Ganetespib Analog Inhibits Extracellular Hsp90-Mediated Cancer Cell Migration that Involves Lysyl Oxidase 2-like Protein. Cancers. 6: 1031-46. PMID 24785146 DOI: 10.3390/Cancers6021031  0.482
2014 Zhao G, Zhu Y, Eno CO, Liu Y, DeLeeuw L, Burlison JA, Chaires JB, Trent JO, Li C. Activation of the proapoptotic Bcl-2 protein bax by a small molecule induces tumor cell apoptosis Molecular and Cellular Biology. 34: 1198-1207. PMID 24421393 DOI: 10.1128/MCB.00996-13  0.312
2008 Donnelly AC, Mays JR, Burlison JA, Nelson JT, Vielhauer G, Holzbeierlein J, Blagg BS. The design, synthesis, and evaluation of coumarin ring derivatives of the novobiocin scaffold that exhibit antiproliferative activity. The Journal of Organic Chemistry. 73: 8901-20. PMID 18939877 DOI: 10.1021/Jo801312R  0.601
2008 Burlison JA, Avila C, Vielhauer G, Lubbers DJ, Holzbeierlein J, Blagg BS. Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines. The Journal of Organic Chemistry. 73: 2130-7. PMID 18293999 DOI: 10.1021/Jo702191A  0.676
2007 Bishop SC, Burlison JA, Blagg BS. Hsp90: a novel target for the disruption of multiple signaling cascades. Current Cancer Drug Targets. 7: 369-88. PMID 17979631 DOI: 10.2174/156800907780809778  0.599
2007 Ansar S, Burlison JA, Hadden MK, Yu XM, Desino KE, Bean J, Neckers L, Audus KL, Michaelis ML, Blagg BS. A non-toxic Hsp90 inhibitor protects neurons from Abeta-induced toxicity. Bioorganic & Medicinal Chemistry Letters. 17: 1984-90. PMID 17276679 DOI: 10.1016/J.Bmcl.2007.01.017  0.592
2006 Burlison JA, Neckers L, Smith AB, Maxwell A, Blagg BS. Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90. Journal of the American Chemical Society. 128: 15529-36. PMID 17132020 DOI: 10.1021/Ja065793P  0.651
2006 Burlison JA, Blagg BS. Synthesis and evaluation of coumermycin A1 analogues that inhibit the Hsp90 protein folding machinery. Organic Letters. 8: 4855-8. PMID 17020320 DOI: 10.1021/Ol061918J  0.689
2003 Young DG, Burlison JA, Peters U. A general approach to medium ring alkynes by using metathesis of cobalt hexacarbonyl containing dienes. The Journal of Organic Chemistry. 68: 3494-7. PMID 12713351 DOI: 10.1021/Jo030011L  0.359
Show low-probability matches.